Fennec Pharmaceuticals Inc (FENC) — Working Capital to Net Assets Ratio
Fennec Pharmaceuticals Inc (FENC) has a Working Capital to Net Assets ratio of 160.0% as of December 2025. Working capital of $56.07 Million (current assets of $66.56 Million minus current liabilities of $10.50 Million) is measured against net assets of $35.05 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See FENC equity to assets ratio to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Fennec Pharmaceuticals Inc Working Capital to Net Assets (1999–2025)
This chart shows how Fennec Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 26 annual periods from 1999 to 2025. As of December 2025, the ratio stands at 160.0%, reflecting working capital of $56.07 Million against net assets of $35.05 Million USD. Check tangible net worth ratio of Fennec Pharmaceuticals Inc to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Fennec Pharmaceuticals Inc (1999–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Fennec Pharmaceuticals Inc from 1999 to 2025, covering 26 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see FENC company net worth.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 160.0% | $56.07 Million | $35.05 Million | $66.56 Million | $10.50 Million | ▲ +793.6 pp |
| 2024 | -633.6% | $37.20 Million | $-5.87 Million | $44.12 Million | $6.92 Million | ▼ -467.5 pp |
| 2023 | -166.1% | $19.30 Million | $-11.62 Million | $26.86 Million | $7.55 Million | ▲ +694.9 pp |
| 2022 | -861.0% | $22.12 Million | $-2.57 Million | $26.73 Million | $4.61 Million | ▼ -992.5 pp |
| 2021 | 131.5% | $20.73 Million | $15.77 Million | $22.39 Million | $1.65 Million | ▲ +31.5 pp |
| 2020 | 100.0% | $29.07 Million | $29.07 Million | $31.42 Million | $2.35 Million | ▲ +2.2 pp |
| 2019 | 97.8% | $11.61 Million | $11.88 Million | $13.88 Million | $2.27 Million | ▼ -2.2 pp |
| 2018 | 100.0% | $21.31 Million | $21.31 Million | $22.95 Million | $1.64 Million | ▲ +0.0 pp |
| 2017 | 100.0% | $26.76 Million | $26.76 Million | $28.40 Million | $1.64 Million | ▲ +0.0 pp |
| 2016 | 100.0% | $3.57 Million | $3.57 Million | $3.97 Million | $402.00K | ▲ +0.0 pp |
| 2015 | 100.0% | $548.00K | $548.00K | $1.02 Million | $471.00K | ▲ +0.0 pp |
| 2014 | 100.0% | $613.00K | $613.00K | $2.37 Million | $1.76 Million | ▲ +0.0 pp |
| 2013 | 100.0% | $-1.46 Million | $-1.46 Million | $1.75 Million | $3.21 Million | ▲ +0.0 pp |
| 2012 | 100.0% | $-4.96 Million | $-4.96 Million | $2.37 Million | $7.32 Million | ▲ +0.0 pp |
| 2011 | 100.0% | $-120.00K | $-120.00K | $5.35 Million | $5.47 Million | ▲ +0.0 pp |
| 2010 | 100.0% | $-4.92 Million | $-4.92 Million | $5.99 Million | $10.92 Million | ▼ -1.7 pp |
| 2009 | 101.7% | $413.00K | $406.00K | $833.00K | $420.00K | ▼ -3.4 pp |
| 2008 | 105.1% | $3.21 Million | $3.05 Million | $5.64 Million | $2.43 Million | ▲ +5.0 pp |
| 2007 | 100.1% | $14.16 Million | $14.15 Million | $16.56 Million | $2.40 Million | ▲ +84.3 pp |
| 2006 | 15.8% | $1.20 Million | $7.58 Million | $5.89 Million | $4.70 Million | ▼ -37.7 pp |
| 2005 | 53.5% | $10.73 Million | $20.06 Million | $13.40 Million | $2.66 Million | ▼ -7.7 pp |
| 2003 | 61.2% | $20.20 Million | $33.00 Million | $21.68 Million | $1.48 Million | ▲ +46.5 pp |
| 2002 | 14.7% | $2.25 Million | $15.31 Million | $3.33 Million | $1.09 Million | ▼ -75.6 pp |
| 2001 | 90.3% | $5.49 Million | $6.08 Million | $6.18 Million | $694.09K | ▼ -5.5 pp |
| 2000 | 95.8% | $9.41 Million | $9.82 Million | $9.94 Million | $525.25K | ▲ +189.2 pp |
| 1999 | -93.4% | $-43.64K | $46.73K | $435.87K | $479.51K | — |